| Subject: | FDA Updates Consumers on Guidant Corporation's Implantable Defibrillators |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Wed, 6 Jul 2005 - 10:00 am |
| The StayAlert Administrator posted a notice on 6-20-05 regarding the FDA recall of certain implantable defibrillators and cardiac resynchronization therapy defibrillators from Guidant Corporation. As of 7-01-05 the FDA has now classified these recalled devices manufactured by Guidant Corporation.
Classifications can fall into three categories, with Class I being the most serious. These numerical classifications are based on the probability that the device failure could lead to adverse health... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
Customizable Documents and Tools:
Related MCN Products:
|
|
StayAlert! provides immediate online healthcare compliance validation to our healthcare users. When faced with dramatic reductions in healthcare dollars, StayAlert! focuses on those processes that can save the most time and money. By automating labor-intensive activities, StayAlert! almost instantly produces a positive impact on the healthcare user's bottom line. The policies alone included with the StayAlert! notices can save you $65,000 or more in labor costs each year. Organizations will realize dramatic cost savings through elimination of labor intensity, increased productivity with the benefit of ensuring regulatory compliance. StayAlert! is the service-oriented supplier of health care's compliance needs. StayAlert! is the only comprehensive clinical and regulatory service providing organizations in the healthcare arena with practical applications to meet complex mandated federal requirements. |
|
